Rankings
▼
Calendar
PRGO FY 2022 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena
PRGO
Perrigo Company plc
$1B
FY 2022 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$4.5B
+7.6% YoY
Gross Profit
$1.5B
32.7% margin
Operating Income
$79M
1.8% margin
Net Income
-$141M
-3.2% margin
EPS (Diluted)
$-0.97
Cash Flow
Operating Cash Flow
$307M
Free Cash Flow
$211M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$11.0B
Total Liabilities
$6.2B
Stockholders' Equity
$4.8B
Cash & Equivalents
$601M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$4.5B
$4.1B
+7.6%
Gross Profit
$1.5B
$1.4B
+2.8%
Operating Income
$79M
$410M
-80.8%
Net Income
-$141M
-$69M
-104.1%
← Q4 2021
All Quarters
Q1 2022 →